Biofrontera Inc. BFRI 深 沪
等待开盘 07-01 09:30:00 美东时间
0.963
-0.057
-5.59%
华盛通- 最 高1.03
- 今 开1.01
- 成交量 21.17万股
- 最 低 0.961
- 昨 收 1.02
- 总市值 1232.96万
- 52周最高 1.19
- 市盈率 静 --
- 换手率 1.65%
- 52周最低 0.5547
- 委 比 29.41%
- 总股本 1280.33万
- 历史最高 292.60
- 量 比 1.47
- 振 幅 6.76%
- 历史最低 0.536
- 每 手 1
- 风险率 0.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高1100美元，花旗、瑞穗、 Melius Research齐上调美光目标价；X-Energy获大小摩等多家机构首予“买入”评级
今日重点评级关注：TD Cowen：维持Strategy"买入"评级，目标价从395美元升至400美元；摩根士丹利：维持Cipher Digital"超配"评级，目标价从40.5美元升至42.5美元
05-20 11:55
Benchmark Downgrades Biofrontera to Speculative Buy, Maintains Price Target to $3
Benchmark analyst Bruce D. Jackson downgrades Biofrontera (NASDAQ:BFRI) from Buy to Speculative Buy and maintains the price target from $3 to $3.
05-19 20:41
美股夜盘 | DirectBooking Technology Co., Ltd. Class A涨38.62%，WEX Inc.涨19.54%
P3 Health Partners Inc. Class A涨-17.63%；Artelo Biosciences Inc涨-14.67%；Lantern Pharma, Inc.涨-12.42%
05-18 08:05
Biofrontera目标2026年实现现金流盈亏平衡 毛利率剑指80%-85%
一季度业绩：营收增长17% 毛利率显著提升至80% Biofrontera近日公布2026年第一季度财报。数据显示，公司一季度产品营收达1010万美元...
05-15 03:09
Transcript: Biofrontera Q1 2026 Earnings Conference Call
On Thursday, Biofrontera (NASDAQ:BFRI) discussed first-quarter financial result...
05-14 23:39
Biofrontera Q1 EPS $(0.41) Misses $(0.12) Estimate, Sales $10.084M Miss $10.250M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.12) by 272.73 percent. This is a 12.77 percent increase over losses of $(0.47) per share from
05-14 20:08
Biofrontera Q1 revenue rises on higher Ameluz sales
Biofrontera Q1 revenue rises on higher Ameluz sales Overview U.S. biopharmaceutical firm's Q1 revenue rose 17% on higher Ameluz sales and price increases Adjusted EBITDA loss narrowed year over year, reflecting improved gross margins under new earnout structure Outlook Company remains focused on ach
05-14 19:40
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
Biofrontera Inc. will report its Q1 2026 financial results on May 14, 2026, after U.S. markets close. A conference call at 11:00 a.m. ET on the same day will discuss the results, provide a business update, and answer questions. The call can be accessed via 1-877-877-1275 (U.S./Canada) or 1-412-858-5202 (international), with a webcast available at https://event.choruscall.com/mediaframe/webcast.html?webcastid=Re1hZKm0. Biofrontera specializes in p...
05-08 20:00
电话会总结 ｜ Biofrontera(BFRI)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Biofrontera业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **季度表现（2025年Q4）：** - 营收达到1,710万美元，创公司历史新高，同比增长36% - 净利润560万美元，较上年同期140万美元净亏损实现扭亏为盈 - 调整后EBITDA为490万美元，较上年同期负140万美元大幅改善630万美元 - 毛利率提升至82%，较上年同期58%显著改善 **全年表现（2025年）：** - 年度营收4,170万美元，同比增长12% - 净亏损1,050万美元，较上年1,780万美元净亏损改善41% - 调整后EBITDA
03-20 12:31
